trial · primary record
Estradiol
Estrogen Receptor Positive Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 19 |
| Primary completion | 2028-06 |
| Primary endpoint | To assess changes in breast cancer proliferation after a 7-14 day trial of estradiol in newly diagnosed estrogen receptor positive post-menopausal breast cancer patients prior to surgery. |
| Registry ID | NCT02238808 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:46.617Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02238808
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.